TMDX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

TransMedics Group Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 76.51 USD
5.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -24.0% below the Trend Line and sits at 17.1% of its 52-week range. The latest completed week returned 5.9%, after a 11.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 33/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 33 out of 100
Latest Close 76.51 USD 31 Jul 2026
1W Return 5.9% latest completed week
4W Return 11.1% short-term follow-through
12W Return 12.8% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.9% Latest completed week; four-week move 11.1%. Indicator stack 31/49 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 33/100 conviction; expected move 17.3%. News sentiment 50/100 69 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -24.0% below the Trend Line and sits at 17.1% of its 52-week range. The latest completed week returned 5.9%, after a 11.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0412-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 11.1% over four weeks, 12.8% over 12 weeks, and -36.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W5.9%
4W11.1%
12W12.8%
26W-42.9%
52W-36.5%
Active trend streak0 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.36Latest activity-pressure read.
Pressure change68.3%Four-week change in activity pressure.
Leadership-37.15Latest relative-leadership reading.
RS change22.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value20/100Relative valuation strength. Underlying universe rank 81; rank 1 is best.
Quality92/100Profitability and accounting quality. Underlying universe rank 9; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth96/100Revenue and earnings growth. Underlying universe rank 5; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework26/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
14.5x
Price divided by trailing earnings.
Price / sales
3.9x
Market value relative to trailing revenue.
EV / EBITDA
20.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
59.1%
Gross profit retained from each unit of revenue.
Operating margin
16.8%
Operating profit retained from revenue.
Free-cash-flow margin
45.5%
Free cash flow generated from revenue.
Return on invested capital
8.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
30.2%
Latest one-year revenue growth.
EPS growth
251.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
78.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.7%
Net share repurchases relative to market value.
Shareholder yield
-0.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

TMDX shows bullish options pressure with a 33/100 conviction score, put-call volume ratio of 0.51, expected move of 17.3%, and Sharemaestro trend signal inactive.

Conviction33/100
Expected move17.3%
Put/call volume0.51
Pressure37
Speculation8
Volatility96
Trend agreement24
Open options detail
Insider activity16 / 2

16 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 69 relevant articles.

14 positive · 45 neutral · 10 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move17.3%Nearest-chain priced movement where available.
52-week drawdown-51.0%Distance below the 52-week high.
13-week volatility10.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+13.2%Week of 10 Apr.
Worst week-32.2%Week of 8 May.
Latest week+5.9%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks0
Modest losses3
Sharp losses9
Recent vol10.7%13-week weekly-return volatility.
Base vol8.5%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew6.2% / -7.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape26/100

Trend, activity pressure, participation, and risk combine to a 26/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.04; No reversal markers Factors36/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 76; Small Cap Core rank 85 SVQF26/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 539.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options45/100

TMDX shows bullish options pressure with a 33/100 conviction score, put-call volume ratio of 0.51, expected move of 17.3%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 17.3% Sentiment50/100

Weighted news tone is neutral across 69 relevant articles.

Transmedics Group Inc (TMDX) Risk Assessment: Volatility, Financial Risk & Investment Risk Insiders16 / 2

16 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202676.51 USD5.9%100.7 USD101.1 USD-0.36-37.154.1MOff
24 Jul 202672.26 USD-2.3%102.2 USD101.1 USD-0.58-41.014.5MOff
17 Jul 202673.98 USD3.9%104.0 USD101.3 USD-0.74-41.113.9MOff
10 Jul 202671.23 USD3.4%105.8 USD101.4 USD-0.89-46.173.7MOff
3 Jul 202668.86 USD0.6%107.6 USD101.5 USD-1.14-47.614.6MOff
26 Jun 202668.44 USD-13.1%109.9 USD101.6 USD-1.35-48.217.2MOff
19 Jun 202678.79 USD8.1%112.5 USD101.7 USD-1.51-43.894.3MOff
12 Jun 202672.91 USD5.0%114.2 USD101.7 USD-1.61-47.385.1MOff
5 Jun 202669.43 USD3.3%115.6 USD101.7 USD-1.54-49.605.8MOff
29 May 202667.20 USD-2.5%117.3 USD101.8 USD-1.46-54.165.8MOff
22 May 202668.94 USD9.1%119.4 USD101.8 USD-1.35-52.336.8MOff
15 May 202663.20 USD-6.8%121.5 USD101.8 USD-1.29-56.389.8MOff
8 May 202667.84 USD-32.2%123.3 USD101.9 USD-1.23-53.9616.5MOff
1 May 2026100.0 USD-9.8%124.6 USD102.0 USD-1.14-29.275.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.